Name and Position

Dr Karl Gaffney

Contact Details

Main Telephone Number:01603 289670
Fax Number: 01603 287004


Special clinical interests: ankylosing spondylitis, rheumatoid arthritis, osteoporosis

Research interests: epidemiology, imaging and therapeutics of spondyloarthropathies

Professional profile: Dr Gaffney qualified with honours in 1988 from University College Dublin. He trained in general medicine and rheumatology in Dublin and at St Bartholomew’s and The Royal London Hospitals. In 1993, he was awarded a 2 year Clinical Research Fellowship by the Arthritis Research Council UK. This work on MRI Quantification of Rheumatoid Synovitis was undertaken at the Bone & Joint Research Unit, Royal London Medical School. In 1995, Dr Gaffney was appointed as Senior Registrar at the Addenbrooke’s Hospital, Cambridge and The Norfolk & Norwich Hospital before taking up his current post.

Besides being a full time rheumatology consultant, Dr Gaffney is also the Clinical Director for Rheumatology, Clinical Research Lead, Honorary Senior Lecturer at the University of East Anglia, Chair of British Society for Rheumatology Biologics Committee for Ankylosing Spondylitis, Medical Advisor and Trustee of the National Ankylosing Spondylitis Society and President of The National Osteoporosis Society (Norwich & District Group). He was Clinical Tutor (Associate Medical Director) from 1999-2005, and Programme Director and Director of Rheumatology Training in the East of England between 2001 and 2011.

Publications: Dr Gaffney has published over 100 papers including;

Correlation between clinical and MRI disease activity scores in axial spondyloarthritis. MacKay J, Aboelmagd S, Gaffney K. Clin Rheum 2015; In press

Delay to Diagnosis in Axial SpA: Are We Improving in the UK? Sykes M, Doll H, Sengupta R, Gaffney K. Rheumatology 2014; In press

An open label, pilot, multi-centre, step-down, randomised controlled trial to examine whether etanercept 25mg once weekly is effective in maintaining a clinical response in patients with ankylosing spondylitis who have responded to 50mg once weekly – The ANSWES trial. Yates M, Elender F, Hamilton L, Dean L, Doll H, Thomas J, Gaffney K. J Rheum 2014; In press

Comment on: ‘Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry’ by Sorensen et al. Sykes M, Doll H, Gaffney K. ARD 2014):1. doi:10.1136/annrheumdis-2014-205589

Prevalence of Inflammatory Back Pain in a UK Primary Care Population. Hamilton LE, MacGregor AJ, Warmington V, Pinch E, Gaffney JK. Rheumatology 2014; 53: 161-164

Validation of a patient self-reported screening questionnaire for axial spondyloarthropathy in a UK population. Hamilton L, Newman D, Belkhiri A, Toms A, MacGregor A, Gaffney K. Spine (Phila Pa 1976) 2013 ;38(6):502-6

Expanding the spectrum of inflammatory spinal disease. AS it was, as it is now. Isdale A, Keat A, Barkham N, Bennett A, Gaffney K, Marzo-Ortega H, Sengupta R. Rheumatology 2013;52:2103-5.